Source:http://linkedlifedata.com/resource/pubmed/id/11681709
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2001-10-29
|
pubmed:abstractText |
The present study demonstrates alterations in the regulation of matrix metalloproteinase-2 (MMP-2) expression in response to insulin like growth factor-1 (IGF-1) in a H-ras transformed cell line, C3, which is capable of metastasis formation. These changes in MMP-2 expression in response to IGF-1 treatment did not occur in either non-transformed parental 10 T 1/2 cells or in H-ras transformed cells (NR3 cells) which are capable of benign tumour formation. IGF-1 treatment of C3 cells resulted in increased expression of MMP-2 gelatinolytic activity and increased expression of MMP-2 mRNA levels. The IGF-1 mediated alterations in MMP-2 mRNA levels were dependent upon de novo protein synthesis and independent of transcriptional events, but dependent upon post-transcriptional regulatory events. Most notably, IGF-1 can regulate MMP-2 mRNA expression in C3 cells through a mechanism involving MMP-2 message stabilization. This study demonstrates aspects of the temporal regulatory mechanisms of MMP-2 expression in response to insulin-like growth factor-1 in a H-ras transformed fibrosarcoma cell line capable of metastasis formation and thereby, provides further insight into the altered growth regulatory program associated with H-ras mediated cellular transformation and malignant progression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cycloheximide,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Synthesis Inhibitors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0300-8177
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
223
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11681709-Animals,
pubmed-meshheading:11681709-Cell Line, Transformed,
pubmed-meshheading:11681709-Cycloheximide,
pubmed-meshheading:11681709-Electrophoresis,
pubmed-meshheading:11681709-Fibrosarcoma,
pubmed-meshheading:11681709-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:11681709-Genes, ras,
pubmed-meshheading:11681709-Insulin-Like Growth Factor I,
pubmed-meshheading:11681709-Matrix Metalloproteinase 2,
pubmed-meshheading:11681709-Matrix Metalloproteinase 9,
pubmed-meshheading:11681709-Mice,
pubmed-meshheading:11681709-Protein Synthesis Inhibitors,
pubmed-meshheading:11681709-RNA Stability,
pubmed-meshheading:11681709-Tumor Cells, Cultured
|
pubmed:year |
2001
|
pubmed:articleTitle |
Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells.
|
pubmed:affiliation |
Department of Laboratory Medicine and Pathobiology, St. Michael 's Hospital and the University of Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article
|